A Case Report on Non-Hodgkin Lymphoma with Spleenomegaly and Pancytopenia: Challenges in Management and Role of Emergency Splenectomy

Abstract The 47-year-old female presented with progressive left-sided abdominal fullness, splenomegaly, and pancytopenia, and was diagnosed with Splenic Marginal Zone Lymphoma (SMZL) through histopathological findings of lymphoid cell infiltration in the spleen and hilar lymph nodes, supported by positive immunohistochemistry and flow cytometry. Despite initial treatment with six doses of Rituximab monotherapy, the patient did not respond, prompting a timely shift to a more systemic management approach with the R-CVP regimen, tailored to her age and thrombocytopenia. When symptoms persisted, an emergency splenectomy was skillfully performed to provide symptomatic relief and enhance survival, with surgical risks meticulously managed.This timely and decisive intervention proved crucial, and the patient has since shown remarkable improvement. At her follow-up visit post-surgery, she is tolerating treatment well and is in good health, demonstrating the success of the comprehensive and adaptive care provided.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-19
DOI
https://doi.org/10.5281/zenodo.14903677
Primary Topic
Carcinogens and Genotoxicity Assessment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case Report on Non-Hodgkin Lymphoma with Spleenomegaly and Pancytopenia: Challenges in Management and Role of Emergency Splenectomy

Zenodo (CERN European Organization for Nuclear Research)
Carcinogens and Genotoxicity Assessment
article

A Case Report on Non-Hodgkin Lymphoma with Spleenomegaly and Pancytopenia: Challenges in Management and Role of Emergency Splenectomy

article en

Abstract

Abstract The 47-year-old female presented with progressive left-sided abdominal fullness, splenomegaly, and pancytopenia, and was diagnosed with Splenic Marginal Zone Lymphoma (SMZL) through histopathological findings of lymphoid cell infiltration in the spleen and hilar lymph nodes, supported by positive immunohistochemistry and flow cytometry. Despite initial treatment with six doses of Rituximab monotherapy, the patient did not respond, prompting a timely shift to a more systemic management approach with the R-CVP regimen, tailored to her age and thrombocytopenia. When symptoms persisted, an emergency splenectomy was skillfully performed to provide symptomatic relief and enhance survival, with surgical risks meticulously managed.This timely and decisive intervention proved crucial, and the patient has since shown remarkable improvement. At her follow-up visit post-surgery, she is tolerating treatment well and is in good health, demonstrating the success of the comprehensive and adaptive care provided.

Zenodo (CERN European Organization for Nuclear Research)
Gender equality
Openalex Percentile: Top 47%
Carcinogens and Genotoxicity Assessment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case Report on Non-Hodgkin Lymphoma with Spleenomegaly and Pancytopenia: Challenges in Management and Role of Emergency Splenectomy · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS